Descripción del Producto
Congratulations! You have found Lumixyl, the first clinically proven medical grade skincare system that dermatologists use to improve skin health and prevent or fade unwanted skin discoloration.
Developed by dermatological researchers at Stanford University, Lumixyl’s ground-breaking Decapeptide-12 is the only peptide shown to measurably aid the skin in restraining tyrosinase, the enzyme responsible for initiating the overproduction of melanin, that can cause uneven pigmentation and dark spots.
Studies show that Decapeptide-12 helps inhibit the production of melanin more efficaciously than hydroquinone – reducing melanin synthesis by as much as 40 percent compared to treatments with hydroquinone, which reduced production by only 7 percent in the same study. These results are one reason Lumixyl is considered by many to be the first real alternative to Hydroquinone.
Reseñas
No hay reseñas todavía.